Subcutaneous delivery of NPA7, first-in-class novel bispecific designer peptide: enhances cardiorenal function and suppresses renin and aldosterone in vivo and in vitro
Event:
ESC Congress 2019
Topic:
Pharmacotherapy
Session:
Heart Failure Basic Science
